Zebrowska-Nawrocka M, Szmajda-Krygier D, Krygier A, Jelen A, Balcerczak E
Int J Mol Sci. 2024; 25(18).
PMID: 39337357
PMC: 11432643.
DOI: 10.3390/ijms25189868.
Damane B, Mulaudzi T, Kader S, Naidoo P, Savkovic S, Dlamini Z
Cancers (Basel). 2023; 15(3).
PMID: 36765706
PMC: 9913377.
DOI: 10.3390/cancers15030748.
Xia R, Xu M, Yang J, Ma X
Mol Biomed. 2022; 3(1):44.
PMID: 36517618
PMC: 9751255.
DOI: 10.1186/s43556-022-00099-8.
Colomer C, Pecharroman I, Bigas A, Espinosa L
Cancer Drug Resist. 2022; 3(3):482-490.
PMID: 35582445
PMC: 8992499.
DOI: 10.20517/cdr.2019.104.
Zhou B, Lin W, Long Y, Yang Y, Zhang H, Wu K
Signal Transduct Target Ther. 2022; 7(1):95.
PMID: 35332121
PMC: 8948217.
DOI: 10.1038/s41392-022-00934-y.
Loss of LKB1-NUAK1 signalling enhances NF-κB activity in a spheroid model of high-grade serous ovarian cancer.
Buensuceso A, Fritz J, Collins O, Valdes Y, Borrelli M, DiMattia G
Sci Rep. 2022; 12(1):3011.
PMID: 35194062
PMC: 8863794.
DOI: 10.1038/s41598-022-06796-2.
Spatial expression of IKK-alpha is associated with a differential mutational landscape and survival in primary colorectal cancer.
Patel M, Pennel K, Quinn J, Hood H, Chang D, Biankin A
Br J Cancer. 2022; 126(12):1704-1714.
PMID: 35173303
PMC: 9174220.
DOI: 10.1038/s41416-022-01729-2.
EPO activates PI3K-IKKα-CDK1 signaling pathway to promote the proliferation of Glial Cells under hypoxia environment.
Hu G, Wang T, Ma C
Genet Mol Biol. 2022; 45(1):e20210249.
PMID: 35167649
PMC: 8846297.
DOI: 10.1590/1678-4685-GMB-2021-0249.
IKKα Induces Epithelial-Mesenchymal Changes in Mouse Skin Carcinoma Cells That Can Be Partially Reversed by Apigenin.
Garcia-Garcia V, Alameda J, Page A, Merida-Garcia A, Navarro M, Tejero A
Int J Mol Sci. 2022; 23(3).
PMID: 35163299
PMC: 8836221.
DOI: 10.3390/ijms23031375.
Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives.
Zhdanovskaya N, Firrincieli M, Lazzari S, Pace E, Scribani Rossi P, Felli M
Cancers (Basel). 2021; 13(20).
PMID: 34680255
PMC: 8533696.
DOI: 10.3390/cancers13205106.
NF-κB-Dependent and -Independent (Moonlighting) IκBα Functions in Differentiation and Cancer.
Espinosa L, Marruecos L
Biomedicines. 2021; 9(9).
PMID: 34572464
PMC: 8468488.
DOI: 10.3390/biomedicines9091278.
A Review: Mechanism of in Cancers-NF-B, P13K/AKT, and MAPKs Signaling Activation.
Saahene R, Agbo E, Barnes P, Yahaya E, Amoani B, Nuvor S
Evid Based Complement Alternat Med. 2021; 2021:4514342.
PMID: 34484390
PMC: 8413045.
DOI: 10.1155/2021/4514342.
NOTCH3, a crucial target of miR-491-5p/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating Akt pathway.
Kang W, Zhang J, Huang T, Zhou Y, Wong C, Chan R
Oncogene. 2021; 40(9):1578-1594.
PMID: 33452458
PMC: 7932926.
DOI: 10.1038/s41388-020-01579-3.
Targeting Notch in oncology: the path forward.
Majumder S, Crabtree J, Golde T, Minter L, Osborne B, Miele L
Nat Rev Drug Discov. 2020; 20(2):125-144.
PMID: 33293690
DOI: 10.1038/s41573-020-00091-3.
Gibberellin JRA-003: A Selective Inhibitor of Nuclear Translocation of IKKα.
Annand J, Henderson A, Cole K, Maurais A, Becerra J, Liu Y
ACS Med Chem Lett. 2020; 11(10):1913-1918.
PMID: 33062173
PMC: 7549252.
DOI: 10.1021/acsmedchemlett.9b00613.
CHUK/IKK-α loss in lung epithelial cells enhances NSCLC growth associated with HIF up-regulation.
Chavdoula E, Habiel D, Roupakia E, Markopoulos G, Vasilaki E, Kokkalis A
Life Sci Alliance. 2019; 2(6).
PMID: 31792060
PMC: 6892436.
DOI: 10.26508/lsa.201900460.
Oncogenic Ras mutant causes the hyperactivation of NF-κB via acceleration of its transcriptional activation.
Tago K, Funakoshi-Tago M, Ohta S, Kawata H, Saitoh H, Horie H
Mol Oncol. 2019; 13(11):2493-2510.
PMID: 31580526
PMC: 6822247.
DOI: 10.1002/1878-0261.12580.
Transcription regulation of : a potential and novel therapeutic target in cancer.
Mitra P
Ann Transl Med. 2019; 6(22):443.
PMID: 30596073
PMC: 6281535.
DOI: 10.21037/atm.2018.09.62.
Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical Pathways.
Hossain F, Sorrentino C, Ucar D, Peng Y, Matossian M, Wyczechowska D
Front Oncol. 2018; 8:575.
PMID: 30564555
PMC: 6289043.
DOI: 10.3389/fonc.2018.00575.
Intestinal epithelial Notch-1 protects from colorectal mucinous adenocarcinoma.
Dunkin D, Iuga A, Mimouna S, Harris C, Haure-Mirande J, Bozec D
Oncotarget. 2018; 9(71):33536-33548.
PMID: 30323897
PMC: 6173356.
DOI: 10.18632/oncotarget.26086.